Atenção!


O atendimento às questões referentes ao Repositório Institucional será interrompido entre os dias 20 de dezembro de 2025 a 4 de janeiro de 2026.

Pedimos a sua compreensão e aproveitamos para desejar boas festas!

Logo do repositório

Inhibition of lysozyme by taurine dibromamine

dc.contributor.authorPetrônio, M. S. [UNESP]
dc.contributor.authorXimenes, V. F. [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.date.accessioned2022-04-29T07:12:40Z
dc.date.available2022-04-29T07:12:40Z
dc.date.issued2013-11-01
dc.description.abstractHypobromous acid (HOBr) is a powerful oxidant produced by stimulated neutrophils and eosinophils. Taurine, a non-protein amino acid present in high amounts in the leukocytes, reacts instantaneously with HOBr leading to their haloamine derivative taurine dibromamine (Tau-NBr2). Lysozyme is a bactericidal enzyme also present in leukocytes and in secretory fluids. The inhibition of lysozyme is a pathway for bacterial proliferation in inflammatory sites. Here, we investigated the inhibition of the enzymatic activity of lysozyme when it was submitted to oxidation by Tau-NBr2. We found that the oxidation of lysozyme by Tau-NBr2 decreased its enzymatic activity in 80%, which was significant higher compared to the effect of its precursor HOBr (30%). The study and comparison of Tau-NBr2 and HOBr regarding the alterations provoked in the intrinsic fluorescence, synchronous fluorescence, resonance light scattering and near and far-UV circular dichroism spectra of lysozyme and oxidized lysozyme revealed that tryptophan residues in the active site of the protein were the main target for Tau-NBr2 and could explain its efficacy as inhibitor of lysozyme enzymatic activity. This property of Tau-NBr2 may have pathological significance, since it can be easily produced in the inflammatory sites. © 2013 Bentham Science Publishers.en
dc.description.affiliationDepartment of Chemistry Faculty of Sciences São Paulo State University (UNESP), 17033-360, Bauru, São Paulo
dc.description.affiliationDepartment of Clinical Analysis School of Pharmaceutical Sciences São Paulo State University (UNESP), 14801-902, Araraquara, São Paulo
dc.description.affiliationUnespDepartment of Chemistry Faculty of Sciences São Paulo State University (UNESP), 17033-360, Bauru, São Paulo
dc.description.affiliationUnespDepartment of Clinical Analysis School of Pharmaceutical Sciences São Paulo State University (UNESP), 14801-902, Araraquara, São Paulo
dc.format.extent1232-1237
dc.identifierhttp://dx.doi.org/10.2174/0929866511320110007
dc.identifier.citationProtein and Peptide Letters, v. 20, n. 11, p. 1232-1237, 2013.
dc.identifier.doi10.2174/0929866511320110007
dc.identifier.issn0929-8665
dc.identifier.scopus2-s2.0-84887939857
dc.identifier.urihttp://hdl.handle.net/11449/227314
dc.language.isoeng
dc.relation.ispartofProtein and Peptide Letters
dc.sourceScopus
dc.subjectEosinophils
dc.subjectHypobromous acid
dc.subjectHypochlorous acid
dc.subjectLysozyme
dc.subjectNeutrophils
dc.subjectTaurine dibromamine
dc.titleInhibition of lysozyme by taurine dibromamineen
dc.typeArtigopt
dspace.entity.typePublication
relation.isDepartmentOfPublicationa83d26d6-5383-42e4-bb3c-2678a6ddc144
relation.isDepartmentOfPublication07a200d2-8576-430b-966f-858ac732e282
relation.isDepartmentOfPublication.latestForDiscoverya83d26d6-5383-42e4-bb3c-2678a6ddc144
unesp.departmentQuímica - FCpt
unesp.departmentAnálises Clínicas - FCFpt

Arquivos